76 related articles for article (PubMed ID: 10612170)
1. [Protection of reproduction function in women with Hodgkin's disease in the course of polychemotherapy].
Ignashina EV; Rasstrigin NA; Margolin OV; Pivnik AV; Shilin DE
Ter Arkh; 1999; 71(10):29-32. PubMed ID: 10612170
[TBL] [Abstract][Full Text] [Related]
2. [The prevention of reproductive disorders occurring during the chemotherapy of women of child-bearing age suffering from Hodgkin's disease].
Ignashina EV; Pivnik AV; Shilin DE; Nasibov OM; Margolin OV; Pustovoĭt LA
Ter Arkh; 1997; 69(11):71-3. PubMed ID: 9483755
[TBL] [Abstract][Full Text] [Related]
3. Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy.
Franke HR; Smit WM; Vermes I
Gynecol Endocrinol; 2005 May; 20(5):274-8. PubMed ID: 16019373
[TBL] [Abstract][Full Text] [Related]
4. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients.
Nitzschke M; Raddatz J; Bohlmann MK; Stute P; Strowitzki T; von Wolff M
Arch Gynecol Obstet; 2010 Jul; 282(1):83-8. PubMed ID: 19967405
[TBL] [Abstract][Full Text] [Related]
5. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease.
Whitehead E; Shalet SM; Blackledge G; Todd I; Crowther D; Beardwell CG
Cancer; 1983 Sep; 52(6):988-93. PubMed ID: 6411321
[TBL] [Abstract][Full Text] [Related]
6. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
7. Gonadal function following chemotherapy for childhood Hodgkin's disease.
Mackie EJ; Radford M; Shalet SM
Med Pediatr Oncol; 1996 Aug; 27(2):74-8. PubMed ID: 8649323
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary results of reproductive system function assessment in young men after Hodgkin's disease therapy].
Moryl-Bujakowska A; Balwierz W; Małek A; Sztefko K
Przegl Lek; 2010; 67(6):382-6. PubMed ID: 21344766
[TBL] [Abstract][Full Text] [Related]
9. Gonadal function and fertility in male survivors treated for Hodgkin's disease in Iran.
Rafsanjani KA; Faranoush M; Hedayatiasl AA; Vossough P
Saudi Med J; 2007 Nov; 28(11):1690-3. PubMed ID: 17965791
[TBL] [Abstract][Full Text] [Related]
10. [Spermato- and steroidogenesis in young men treated for non-Hodgkin's and Hodgkin's lymphoma during childhood].
Krawczuk-Rybak M; Solarz E; Gadomski J; Matysiak M; Wołczyński S
Med Wieku Rozwoj; 2006; 10(3 Pt 1):623-30. PubMed ID: 17317893
[TBL] [Abstract][Full Text] [Related]
11. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
van Beek RD; van den Heuvel-Eibrink MM; Laven JS; de Jong FH; Themmen AP; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Pieters R; de Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 2007 Oct; 92(10):3869-74. PubMed ID: 17726078
[TBL] [Abstract][Full Text] [Related]
12. Effect of cancer polychemotherapy on gonadal function in Hodgkin's disease in adult men.
Rao SV; Murugesan K; Vij U; Sarin R; Kapur BM
Indian J Med Res; 1988 Jan; 87():37-41. PubMed ID: 3360481
[No Abstract] [Full Text] [Related]
13. Amenorrhea in patients with Hodgkin's disease treated with antineoplastic agents.
Sobrinho LG; Levine RA; DeConti RC
Am J Obstet Gynecol; 1971 Jan; 109(1):135-9. PubMed ID: 5538962
[No Abstract] [Full Text] [Related]
14. [Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
Raya Sánchez JM; González Brito G; Hernández Nieto L; Brito Barroso ML; Alvarez Argüelles H; Jorge Hernández JA; Martín Herrera A
Sangre (Barc); 1994 Dec; 39(6):461-4. PubMed ID: 7855699
[TBL] [Abstract][Full Text] [Related]
15. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
Henry-Amar M
J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491
[TBL] [Abstract][Full Text] [Related]
16. [Nephrotic syndrome in Hodgkin's disease].
Miltényi Z; Keresztes K; Ujhelyi L; Kovács J; Illés A
Orv Hetil; 2005 Jun; 146(25):1357-60. PubMed ID: 16106759
[TBL] [Abstract][Full Text] [Related]
17. Classification of secondary amenorrhea based on distinct hormonal patterns.
Kletzky OA; Davajan V; Nakamura RM; Mishell DR
J Clin Endocrinol Metab; 1975 Oct; 41(4):660-8. PubMed ID: 1176579
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of serious meno- and metrorrhagias in hematologic diseases with ovulation inhibitors].
Braunsteiner H; Dienstl F
Blut; 1967 Apr; 15(1):31-3. PubMed ID: 6025964
[No Abstract] [Full Text] [Related]
19. [Cardiogenic shock during polychemotherapy in a patient with Hodgkin's disease].
Drzewoski J; Chojnowski K; Olszańska-Skorek T; Krykowski E
Kardiol Pol; 1986; 29(8):555-9. PubMed ID: 2435945
[No Abstract] [Full Text] [Related]
20. [Long-term results of polychemotherapy for Hodgkin's disease in children].
Kolygin BA
Vopr Onkol; 2003; 49(4):501-4. PubMed ID: 14569946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
